QIAGEN Clinical Insight®: new tool for clinical labs interpreting and reporting on genomic variants

9 June 2015 - 1:30pm by Rolando Garcia-Milian

QUIAGEN has announced the launching of its new tool Clinical Insight® (QCI)  for interpreting and reporting on genomic variant resulting from next-generation sequencing.  According to this company, the new tool can classify variant, identify treatment options, and perform geographical clinical trial matching. QCI has been evaluated in collaboration with Emory University School of Medicine and Dartmouth-Hitchcock Medical Center, among 50 other groups.  Clinical Insight® for Somatic Cancer provides clinical decision support for routine somatic cancer testing laboratories. QUIAGEN’s knowledge base contains millions of expert-curated biomedical finding and mutations from the literature and public databases that is used to build up-to-date pathways and networks related to diseases and drugs. The Cushing/Whitney Medical library provides access to two concurrent seats of QUIAGEN’s Ingenuity Pathway Analysis.

For questions on accessing IPA or any other knowledge based product (MetaCore, BIOBASE, etc.) through the medical library, please contact Rolando Milian

Join the End-User Bioinformatics Network (EBNET) and become a member of a community that collaborates on end-user bioinformatics events, training sessions, resources, and tools that support biomedical research.